Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Daptomycin | 1 | 2018 | 64 | 0.69 | Why? |
| Enterococcus faecium | 1 | 2018 | 95 | 0.67 | Why? |
| Trans-Activators | 1 | 2018 | 170 | 0.66 | Why? |
| Linezolid | 1 | 2018 | 160 | 0.65 | Why? |
| Genome, Bacterial | 2 | 2019 | 446 | 0.60 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.57 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.46 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.41 | Why? |
| Staphylococcal Infections | 2 | 2019 | 1099 | 0.40 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.39 | Why? |
| RNA Polymerase II | 2 | 2018 | 29 | 0.37 | Why? |
| Genome, Viral | 7 | 2021 | 13157 | 0.33 | Why? |
| Phylogeny | 11 | 2021 | 13341 | 0.30 | Why? |
| Birds | 2 | 2018 | 412 | 0.30 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 572 | 0.25 | Why? |
| Virulence | 3 | 2019 | 2172 | 0.25 | Why? |
| Orthomyxoviridae Infections | 2 | 2018 | 1001 | 0.22 | Why? |
| Respiratory System Abnormalities | 1 | 2018 | 3 | 0.20 | Why? |
| Craniosynostoses | 1 | 2018 | 5 | 0.20 | Why? |
| Terminator Regions, Genetic | 1 | 2018 | 3 | 0.20 | Why? |
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 10 | 0.19 | Why? |
| Influenza A Virus, H3N8 Subtype | 1 | 2018 | 20 | 0.19 | Why? |
| RNA Splicing | 1 | 2018 | 119 | 0.18 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.18 | Why? |
| Vancomycin Resistance | 1 | 2018 | 55 | 0.18 | Why? |
| Influenza A virus | 3 | 2018 | 2234 | 0.18 | Why? |
| Horse Diseases | 1 | 2018 | 101 | 0.17 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.17 | Why? |
| Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.17 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.17 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.15 | Why? |
| Influenza in Birds | 2 | 2018 | 528 | 0.15 | Why? |
| Colombia | 4 | 2021 | 1241 | 0.15 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.15 | Why? |
| Genes, Bacterial | 1 | 2017 | 207 | 0.15 | Why? |
| Face | 1 | 2018 | 301 | 0.14 | Why? |
| Cats | 1 | 2021 | 1890 | 0.14 | Why? |
| New York City | 4 | 2021 | 7432 | 0.14 | Why? |
| Organ Specificity | 1 | 2018 | 1070 | 0.13 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.13 | Why? |
| Ecosystem | 1 | 2018 | 776 | 0.12 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.12 | Why? |
| Genes, Viral | 1 | 2018 | 1428 | 0.12 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.12 | Why? |
| Dog Diseases | 1 | 2018 | 745 | 0.11 | Why? |
| Animals, Wild | 1 | 2018 | 1028 | 0.11 | Why? |
| Autism Spectrum Disorder | 1 | 2018 | 587 | 0.11 | Why? |
| Bipolar Disorder | 1 | 2018 | 744 | 0.10 | Why? |
| Military Personnel | 1 | 2020 | 1097 | 0.10 | Why? |
| Feces | 2 | 2021 | 4235 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.10 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.09 | Why? |
| Transients and Migrants | 1 | 2021 | 1468 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.09 | Why? |
| Gastrointestinal Microbiome | 1 | 2021 | 1961 | 0.09 | Why? |
| Evolution, Molecular | 2 | 2018 | 3691 | 0.09 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Mutation | 4 | 2021 | 12376 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.08 | Why? |
| Genetic Variation | 1 | 2020 | 3919 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2018 | 2984 | 0.08 | Why? |
| Chile | 2 | 2021 | 1095 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.07 | Why? |
| Animals | 9 | 2021 | 78931 | 0.07 | Why? |
| Mice | 3 | 2019 | 21357 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 32 | 0.06 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.06 | Why? |
| Binding, Competitive | 1 | 2021 | 264 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| South Carolina | 1 | 2020 | 134 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.05 | Why? |
| Venezuela | 1 | 2020 | 172 | 0.05 | Why? |
| Indians, South American | 1 | 2021 | 126 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.05 | Why? |
| Cloaca | 1 | 2018 | 36 | 0.05 | Why? |
| Craniofacial Dysostosis | 1 | 2018 | 2 | 0.05 | Why? |
| Mupirocin | 1 | 2019 | 22 | 0.05 | Why? |
| Cranial Sutures | 1 | 2018 | 3 | 0.05 | Why? |
| Acrocephalosyndactylia | 1 | 2018 | 3 | 0.05 | Why? |
| Mice, Mutant Strains | 1 | 2018 | 42 | 0.05 | Why? |
| Cartilage | 1 | 2018 | 27 | 0.05 | Why? |
| Chondrocytes | 1 | 2018 | 35 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.05 | Why? |
| Embryo, Mammalian | 1 | 2018 | 86 | 0.05 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Exosome Multienzyme Ribonuclease Complex | 1 | 2017 | 5 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2018 | 159 | 0.04 | Why? |
| Chromatin Immunoprecipitation | 1 | 2017 | 53 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Hemagglutinins, Viral | 1 | 2018 | 176 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Protein Isoforms | 1 | 2018 | 347 | 0.04 | Why? |
| Chlorhexidine | 1 | 2019 | 176 | 0.04 | Why? |
| Horses | 1 | 2018 | 474 | 0.04 | Why? |
| Reassortant Viruses | 1 | 2018 | 287 | 0.04 | Why? |
| Neuraminidase | 1 | 2018 | 289 | 0.04 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.04 | Why? |
| Ribosomes | 1 | 2017 | 200 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Plasmids | 1 | 2019 | 840 | 0.04 | Why? |
| Polymorphism, Genetic | 1 | 2003 | 1074 | 0.04 | Why? |
| Spatial Analysis | 1 | 2021 | 878 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Argentina | 1 | 2018 | 1141 | 0.03 | Why? |
| Selection, Genetic | 1 | 2018 | 691 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2018 | 415 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Exoribonucleases | 1 | 2017 | 455 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Nose | 1 | 2018 | 1093 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2017 | 469 | 0.03 | Why? |
| A549 Cells | 1 | 2017 | 2066 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Viral Matrix Proteins | 1 | 2018 | 1243 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Plasma | 1 | 2017 | 1809 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2018 | 2676 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Obesity | 1 | 2003 | 7388 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2003 | 6166 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2003 | 8207 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
van Bakel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(223)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_